223 related articles for article (PubMed ID: 11304693)
1. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice.
Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC
Int J Cancer; 2001 May; 92(4):568-76. PubMed ID: 11304693
[TBL] [Abstract][Full Text] [Related]
2. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
3. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.
Kordon EC; McKnight RA; Jhappan C; Hennighausen L; Merlino G; Smith GH
Dev Biol; 1995 Mar; 168(1):47-61. PubMed ID: 7883078
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta1 and TGFalpha contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium.
Booth BW; Jhappan C; Merlino G; Smith GH
Int J Cancer; 2007 Feb; 120(3):493-9. PubMed ID: 17096338
[TBL] [Abstract][Full Text] [Related]
5. Reducing mammary cancer risk through premature stem cell senescence.
Boulanger CA; Smith GH
Oncogene; 2001 Apr; 20(18):2264-72. PubMed ID: 11402321
[TBL] [Abstract][Full Text] [Related]
6. Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.
Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A; Henne-Bruns D; Peifer C; Leithäuser F; Deppert W; Knippschild U
PLoS One; 2012; 7(1):e29709. PubMed ID: 22235331
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
8. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
9. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
10. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
Schroeder JA; Troyer KL; Lee DC
Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
[TBL] [Abstract][Full Text] [Related]
11. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression.
Boulanger CA; Wagner KU; Smith GH
Oncogene; 2005 Jan; 24(4):552-60. PubMed ID: 15580303
[TBL] [Abstract][Full Text] [Related]
12. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
[TBL] [Abstract][Full Text] [Related]
14. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis.
Mack DL; Boulanger CA; Callahan R; Smith GH
Breast Cancer Res; 2007; 9(4):R42. PubMed ID: 17626637
[TBL] [Abstract][Full Text] [Related]
15. Cre-mediated gene deletion in the mammary gland.
Wagner KU; Wall RJ; St-Onge L; Gruss P; Wynshaw-Boris A; Garrett L; Li M; Furth PA; Hennighausen L
Nucleic Acids Res; 1997 Nov; 25(21):4323-30. PubMed ID: 9336464
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
18. Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.
Bruno RD; Boulanger CA; Smith GH
Oncogene; 2012 Jan; 31(1):60-7. PubMed ID: 21666720
[TBL] [Abstract][Full Text] [Related]
19. Aberrant development of mammary glands, but precocious expression of beta-casein in transgenic females ubiquitously expressing whey acidic protein transgene.
Iwamori T; Oosawa M; Nukumi N; Kano K; Sudo K; Naito K; Tojo H
J Reprod Dev; 2005 Oct; 51(5):579-92. PubMed ID: 16195641
[TBL] [Abstract][Full Text] [Related]
20. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
